Michael Oberreiter: By 2050, Cancer Diagnoses Will Surge By 77%
Michael Oberreiter/ LinkedIn

Michael Oberreiter: By 2050, Cancer Diagnoses Will Surge By 77%

Michael Oberreiter, Head of Global Access at Roche, shared a post on LinkedIn:

By 2050, cancer diagnoses will surge by 77%. If you believe our current systems are merely ‘stressed’,  you are miscalculating the future. We aren’t just facing a resource shortage. We are approaching a total systemic breaking point.

Maintaining our reactive, hospital-heavy model isn’t playing it safe – it’s a fiscal and humanitarian gamble we are destined to lose. The latest All.Can International report provides the blueprint to stop viewing cancer as an inevitable drain on the state and start managing it as a strategic investment in our collective future.

The shift must be decisive, and it must start now:

  • we must move care out of the ‘hospital fortress’ and into the community. If we don’t break the bottleneck now, the bottleneck will break us.
  • we need financing models that reward early intervention. Paying for late-stage crisis management is the fastest way to bankrupt a national budget.
  • it’s time to stop treating oncology as a line-item burden. Innovation in cancer care is an economic engine that protects our workforce and our GDP.

Moving care closer to the individual isn’t just about empathy – even though this is a significant factor. It is the only path to economic and clinical viability. We can either evolve the model to meet the coming wave, or we can watch the system succumb to it.”

See the 7 actionable steps for a sustainable future.

Michael Oberreiter: By 2050, Cancer Diagnoses Will Surge By 77%

Other Articles Featuring Michael Oberreiter on OncoDaily.